Literature DB >> 16365454

Class IB-phosphatidylinositol 3-kinase (PI3K) deficiency ameliorates IA-PI3K-induced systemic lupus but not T cell invasion.

Domingo F Barber1, Almira Bartolomé, Carmen Hernandez, Juana M Flores, Cristina Fernandez-Arias, Luis Rodríguez-Borlado, Emilio Hirsch, Matthias Wymann, Dimitrios Balomenos, Ana C Carrera.   

Abstract

Class I PI3K catalyzes formation of 3-poly-phosphoinositides. The family is divided into IA isoforms, activated by Tyr kinases and the IB isoform (PI3Kgamma), activated by G protein-coupled receptors. Mutations that affect PI3K are implicated in chronic inflammation, although the differential contribution of each isoform to pathology has not been elucidated. Enhanced activation of class IA-PI3K in T cells extends CD4+ memory cell survival, triggering an invasive lymphoproliferative disorder and systemic lupus. As both IA- and IB-PI3K isoforms regulate T cell activation, and activated pathogenic CD4+ memory cells are involved in triggering systemic lupus, we examined whether deletion of IB could reduce the pathological consequences of increased IA-PI3K activity. IB-PI3Kgamma deficiency did not abolish invasion or lymphoproliferation, but reduced CD4+ memory cell survival, autoantibody production, glomerulonephritis, and systemic lupus. Deletion of the IB-PI3Kgamma isoform thus decreased survival of pathogenic CD4+ memory cells, selectively inhibiting systemic lupus development. These results validate the PI3Kgamma isoform as a target for systemic lupus erythematosus treatment.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16365454     DOI: 10.4049/jimmunol.176.1.589

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  27 in total

Review 1.  Phosphoinositide 3-kinase controls early and late events in mammalian cell division.

Authors:  Zaira García; Amit Kumar; Miriam Marqués; Isabel Cortés; Ana C Carrera
Journal:  EMBO J       Date:  2006-01-26       Impact factor: 11.598

2.  T cell receptor-induced phosphoinositide-3-kinase p110delta activity is required for T cell localization to antigenic tissue in mice.

Authors:  Sarah J Jarmin; Rachel David; Liang Ma; Jan-Guo Chai; Hamlata Dewchand; Aya Takesono; Anne J Ridley; Klaus Okkenhaug; Federica M Marelli-Berg
Journal:  J Clin Invest       Date:  2008-03       Impact factor: 14.808

3.  The p110gamma isoform of phosphatidylinositol 3-kinase regulates migration of effector CD4 T lymphocytes into peripheral inflammatory sites.

Authors:  Molly S Thomas; Jason S Mitchell; Christopher C DeNucci; Amanda L Martin; Yoji Shimizu
Journal:  J Leukoc Biol       Date:  2008-06-03       Impact factor: 4.962

4.  Duvelisib, an oral dual PI3K-δ,γ inhibitor, shows clinical and pharmacodynamic activity in chronic lymphocytic leukemia and small lymphocytic lymphoma in a phase 1 study.

Authors:  Susan O'Brien; Manish Patel; Brad S Kahl; Steven M Horwitz; Francine M Foss; Pierluigi Porcu; Jeffrey Jones; Jan Burger; Nitin Jain; Kerstin Allen; Kerrie Faia; Mark Douglas; Howard M Stern; Jennifer Sweeney; Patrick Kelly; Virginia Kelly; Ian Flinn
Journal:  Am J Hematol       Date:  2018-10-20       Impact factor: 10.047

Review 5.  T cell signaling abnormalities contribute to aberrant immune cell function and autoimmunity.

Authors:  Vaishali R Moulton; George C Tsokos
Journal:  J Clin Invest       Date:  2015-05-11       Impact factor: 14.808

Review 6.  PI3Ks in lymphocyte signaling and development.

Authors:  Klaus Okkenhaug; David A Fruman
Journal:  Curr Top Microbiol Immunol       Date:  2010       Impact factor: 4.291

7.  PI3Kγ deletion reduces variability in the in vivo osteolytic response induced by orthopaedic wear particles.

Authors:  Edward M Greenfield; Joscelyn M Tatro; Matthew V Smith; Erik A Schnaser; Dianqing Wu
Journal:  J Orthop Res       Date:  2011-04-27       Impact factor: 3.494

Review 8.  Systems biology of lupus: mapping the impact of genomic and environmental factors on gene expression signatures, cellular signaling, metabolic pathways, hormonal and cytokine imbalance, and selecting targets for treatment.

Authors:  Andras Perl
Journal:  Autoimmunity       Date:  2010-02       Impact factor: 2.815

9.  Loss of phosphoinositide 3-kinase gamma decreases migration and activation of phagocytes but not T cell activation in antigen-induced arthritis.

Authors:  Michael Gruen; Christina Rose; Christian König; Mieczyslaw Gajda; Reinhard Wetzker; Rolf Bräuer
Journal:  BMC Musculoskelet Disord       Date:  2010-04-07       Impact factor: 2.362

10.  Shared signaling networks active in B cells isolated from genetically distinct mouse models of lupus.

Authors:  Tianfu Wu; Xiangmei Qin; Zoran Kurepa; Kirthi Raman Kumar; Kui Liu; Hasna Kanta; Xin J Zhou; Anne B Satterthwaite; Laurie S Davis; Chandra Mohan
Journal:  J Clin Invest       Date:  2007-08       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.